NISHITH.TV
  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York

Locations

  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York
  • Content
  • Home
  • ABOUT US
  • NDA in the Media
  • Areas of Service
  • Research and Articles
  • Opportunities
  • Contact
  • NDACloud
  • Client Access
  • Member Access
  • Events and Calender
  • How we perform
  • Knowledge anywhere, anytime
  • See our recent deals
  • Up to date legal developments
  • Case studies in M&A

Research and Articles

HTMLPDF

  • Research at NDA
  • Research Papers
  • Research Articles
  • NDA Think Tanks
  • NDA Hotline
  • New Ali Gunjan
  • Japan Desk ジャパンデスク

NDA-Hotline


  • Capital Markets Hotline
  • Companies Act Series
  • Climate Change Related Legal Issues
  • Competition Law Hotline
  • Corpsec Hotline
  • Court Corner
  • Cross Examination
  • Deal Destination
  • Debt Funding in India Series
  • Dispute Resolution Hotline
  • Education Sector Hotline
  • FEMA Hotline
  • Financial Service Update
  • Food & Beverages Hotline
  • Funds Hotline
  • Gaming Law Wrap
  • GIFT City Express
  • Green Hotline
  • HR Law Hotline
  • iCe Hotline
  • Insolvency and Bankruptcy Hotline
  • International Trade Hotlines
  • Investment Funds: Monthly Digest
  • IP Hotline
  • IP Lab
  • Legal Update
  • Lit Corner
  • M&A Disputes Series
  • M&A Hotline
  • M&A Interactive
  • Media Hotline
  • New Publication
  • Other Hotline
  • Pharma & Healthcare Update
  • Private Client Wrap
  • Private Debt Hotline
  • Private Equity Corner
  • Real Estate Update
  • Realty Check
  • Regulatory Digest
  • Regulatory Hotline
  • Renewable Corner
  • SEZ Hotline
  • Social Sector Hotline
  • Tax Hotline
  • Technology & Tax Series
  • Technology Law Analysis
  • Telecom Hotline
  • The Startups Series
  • White Collar and Investigations Practice
  • Yes, Governance Matters.
  • Japan Desk ジャパンデスク

Pharma & Healthcare Update

April 1, 2021

Commercialisation of healthcare in India: overview

India is home to some of the world’s largest pharmaceutical companies and makes a significant contribution to the global output of drugs each year. India’s reputation as the pharmacy of the world has only grown in recent years. In the medical device sector as well, India is on its way to making a mark globally. The growth of the Indian pharmaceutical and medical device industry can be attributed in part to the well-established regulatory framework governing drugs and medical devices manufactured and marketed in India. Medicinal products have been regulated in India since the 1940s and the government has been making efforts in recent years to ensure the manner of regulating drugs and medical devices is in line with global standards. This has encouraged many foreign players to consider marketing their products in India as well as sourcing their products from India to meet the demand in other jurisdictions.

In this guide, Dr. Milind Antani, Darren Punnen and Shreya Shenolikar provide a comprehensive overview of the regulatory framework applicable to drugs and medical devices. The guide covers the entire supply chain from approval of drugs and medical devices to their sale to the end consumer. They have also provided information on the manner in which pharmaceutical adjacent products such as alternative medicinal products and nutraceuticals are regulated.

The complete article can be accessed here.

Reproduced from Practical Law with the permission of the publishers. For further information, visit practicallaw.com

 

– Shreya Shenolikar, Darren Punnen & Dr. Milind Antani

You can direct your queries or comments to the authors

Mission and Vision


Distinctly Different

What's New


Differential economic rights of AIF LPs under threat
Investment Funds: Monthly Digest: May 31,2023
Manner of computation of Net Winnings prescribed for online gaming companies!
Tax Hotline : May 30,2023

Events


Webinars

Generative Artificial Intelligence: Legal, Ethical and Policy Implications
June 01,2023 - June 01,2023

Seminar

Winning Together: Exploring the dynamics of India-Singapore relations for Fund Structuring and Deal Making
April 26,2023 - April 26,2023

This event is over. For event material please click here


Round Table

Investing In Net Zero
July 22,2022 - July 22,2022

This event is over. For event material please click here

News Roundup


News Articles

Naked Licensing in Trademarks
April 14,2023

Quotes

AI holds massive potential for malicious use, but who will be held accountable?
May 25,2023

Newsletters


Investment Funds: Monthly Digest

Differential economic rights of AIF LPs under threat
May 31,2023

Tax Hotline

Manner of computation of Net Winnings prescribed for online gaming companies!
May 30,2023

New Publication

Time for Evolution of Sport Adjudication in India
May 29,2023

  • Disclaimer
  • Content
  • Feedback
  • Walkthrough
  • Subscribe
Nishith Desai Associates@2016 All rights reserved.